Ping Chen
Impact in
- Virology top 1%
- HIV Research and Treatment
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Oncology 85
-
- RNA Interference and Gene Delivery 23
- RNA modifications and cancer 14
- Advanced biosensing and bioanalysis techniques 11
- Co-authors
- Benjamin K. Chen (5 shared papers)Wolfgang Hübner (3 shared papers)Matthew A. Spinelli (1 shared paper)Xia Zhao (3 shared papers)Jianjun Chen (4 shared papers)Colleen F. Hanrahan (1 shared paper)Carol A. Nacy (1 shared paper)Xiao-Qi Yu (9 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (16 papers)Journal of Medicinal Chemistry (9 papers)PLoS ONE (7 papers)Frontiers in Oncology (7 papers)Advanced Science (5 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ping Chen
367 papers receiving 9.5k citations
Peers
Comparison fields: 5 of 162
- Virology 579
- Cancer Research 1.5k
- Molecular Biology 4.2k
- Oncology 1.4k
- Immunology 1.1k
Countries citing papers authored by Ping Chen
This map shows the geographic impact of Ping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Chen more than expected).
Fields of papers citing papers by Ping Chen
This network shows the impact of papers produced by Ping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Chen. The network helps show where Ping Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Ping Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 378 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 372 | |
| 2 | 2005 | 316 | |
| 3 | 2013 | 234 | |
| 4 | 2007 | 201 | |
| 5 | 2021 | 170 | |
| 6 | 2021 | 158 | |
| 7 | 2021 | 152 | |
| 8 | 2014 | 143 | |
| 9 | 2012 | 140 | |
| 10 | 2013 | 137 | |
| 11 | 2012 | 134 | |
| 12 | 2010 | 121 | |
| 13 | 2016 | 110 | |
| 14 | 2023 | 106 | |
| 15 | 2017 | 104 | |
| 16 | 2018 | 103 | |
| 17 | 2013 | 98 | |
| 18 | 2011 | 98 | |
| 19 | 1998 | 94 | |
| 20 | 2017 | 93 |
About Ping Chen
Ping Chen is a scholar working on Oncology, Molecular Biology, Cancer Research, Immunology and Epidemiology, having authored 378 papers that have together received 9.7k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (23 papers), MicroRNA in disease regulation (21 papers), Immunotherapy and Immune Responses (17 papers), Cancer-related molecular mechanisms research (15 papers), RNA modifications and cancer (14 papers), Virus-based gene therapy research (13 papers), Immune Cell Function and Interaction (12 papers) and Advanced biosensing and bioanalysis techniques (11 papers). The work is most often cited by research in Virology (579 citations), Cancer Research (1.5k citations), Molecular Biology (4.2k citations), Oncology (1.4k citations) and Immunology (1.1k citations). Ping Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Benjamin K. Chen, Wolfgang Hübner, Matthew A. Spinelli, Xia Zhao, Jianjun Chen, Colleen F. Hanrahan, Carol A. Nacy, Xiao-Qi Yu, Marina N. Protopopova and Борис Владимирович Никоненко. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, PLoS ONE, Frontiers in Oncology and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.